IP Library Granted Patent US 8,673,577
Granted Patent B2
US 8,673,577 · App. 13/579,906 · Granted Mar 18, 2014

Method for examining acute renal disorder

Inventors: Masanori Hara (Niigata, JP); Hiroyuki Kurosawa (Gosen, JP); Shinya Ogasawara (Gosen, JP); Yoshiaki Hirayama (Gosen, JP)
Assignees: Masanori Hara; Denka Seiken Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,673,577
App. No.
13/579,906
Granted
Mar 18, 2014
Kind
B2
Abstract

Provided is a test method for acute kidney injury, including detecting urinary podocalyxin. According to the test method, a subject to be tested who has a higher value for the urinary podocalyxin than a reference value can be assessed to have acute kidney injury. Further, as compared to a conventional method, the test method allows acute kidney injury to be assessed accurately and non-invasively, which allows a physical burden on a patient to be reduced. Thus, the test method is useful.

Claims (11)

1. A test method for determining acute kidney injury in a subject, said method comprising:

adding a treatment liquid to a urine sample of a subject to produce a urine sample solution comprising a solubilized podocalyxin;

detecting the level of solubilized podocalyxin in said urine sample solution; and

correlating the level of solubilized podocalyxin with the presence of acute kidney injury in said subject.

2. A test method according to claim 1 , wherein said step of correlating the level of solubilized podocalyxin comprises comparing the level of solubilized podocalyxin with a reference value, and wherein said level of solubilized podocalyxin higher than said reference value is indicative of the presence of acute kidney injury.

3. A test method according to claim 2 , wherein the reference value comprises a value for an upper limit of a 95% confidence interval of a value for urinary podocalyxin in a healthy subject.

4. A test method according to claim 1 , wherein the value for the urinary podocalyxin comprises a value corrected with a value for a urinary component.

5. A test method according to claim 4 , wherein the urinary component comprises urinary creatinine.

6. A test method according to claim 1 , wherein the acute kidney injury comprises acute kidney injury due to acute tubular injury.

7. A test method according to claim 1 , wherein the detecting of the urinary podocalyxin is performed by an immunological technique.

8. A test method according to claim 7 , wherein a test reagent comprising an anti-podocalyxin antibody is used for detecting urinary podocalyxin.

Assignments (2)
CHANGE OF NAME Recorded Sep 29, 2020
From: DENKA SEIKEN CO., LTD.
To: DENKA COMPANY LIMITED
Reel/Frame 053926/0851 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2012
From: HARA, MASANORI; KUROSAWA, HIROYUKI; OGASAWARA, SHINYA; HIRAYAMA, YOSHIAKI
To: HARA, MASANORI; DENKA SEIKEN CO., LTD.
Reel/Frame 028808/0614 →
Priority Claims (1)
JP 2010-041748 · Feb 26, 2010 · national
Continuity (1)
Related Publication 20120322087A1 · Dec 20, 2012